Publications by authors named "Ali Shojaee"

Claim this Profile
U
Utilization of Rehabilitation Services by Disabled People under the Iranian Health Insurance Organization.
Samira Arabi, Mohammad Mahdi Nasehi, Zahra Shahali, Ali Shojaee, Mohsen Dehghani

Med J Islam Repub Iran· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization Trend of Parenteral Antidiabetic Drugs in Type 2 Diabetic Patients Covered by Iran Health Insurance Organization from 2011 to 2030.
Ali Shojaee, Ali Akbari Sari, Farshad Farzadfar, Majid Davari, Rajabali Daroudi

Iran J Public Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data.
Mohammad-Reza Malekpour, Mohsen Abbasi-Kangevari, Ali Shojaee, Sahar Saeedi Moghaddam, Seyyed-Hadi Ghamari

Front Public Health· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National geographical pattern of COVID-19 hospitalization, case fatalities, and associated factors in patients covered by Iran Health Insurance Organization.
Soheila Damiri, Ali Shojaee, Mohsen Dehghani, Zahra Shahali, Sadrollah Abbasi

BMC Public Health· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.
Stacie Ittershagen, Solveig Ericson, Lamis Eldjerou, Ali Shojaee, Eric Bleickardt

Curr Hematol Malig Rep· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing head computed tomography after mild traumatic brain injury: Screening value of clinical findings and S100B protein levels.
Shadi Asadollahi, Kamran Heidari, Mehrdad Taghizadeh, Arash Mohammad Seidabadi, Morteza Jamshidian, Ali Habibzade Shojaee

Brain Inj· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined covalent and noncovalent carboxylation of carbon nanotubes for sensitivity enhancement of clinical immunosensors.
Jinesh Niroula, Gayan Premaratne, S Ali Shojaee, Don A Lucca, Sadagopan Krishnan

Chem Commun (Camb)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superiority of Graphene over Polymer Coatings for Prevention of Microbially Induced Corrosion.
Ajay Krishnamurthy, Venkataramana Gadhamshetty, Rahul Mukherjee, Bharath Natarajan, Osman Eksik, S Ali Shojaee

Sci Rep· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epoxy nanocomposites with two-dimensional transition metal dichalcogenide additives.
Osman Eksik, Jian Gao, S Ali Shojaee, Abhay Thomas, Philippe Chow

ACS Nano· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy/safety of a fixed-dose amlodipine/olmesartan medoxomil-based treatment regimen in hypertensive blacks and non-blacks with uncontrolled BP on prior antihypertensive monotherapy.
Shawna Nesbitt, Ali Shojaee, Jen-Fue Maa

J Clin Hypertens (Greenwich)· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
Matthew R Weir, Ali Shojaee, Jen-Fue Maa

Postgrad Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
Willa A Hsueh, Ali Shojaee, Jen-Fue Maa, Joel M Neutel

Curr Med Res Opin· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
Henry Punzi, Ali Shojaee, Jen-Fue Maa,

Ther Adv Cardiovasc Dis· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Joel Neutel, Ali Shojaee, Jen-Fue Maa

Adv Ther· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.
Joel Neutel, Dean J Kereiakes, Kathy A Stoakes, Jen-Fue Maa, Ali Shojaee

Drugs Aging· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
Matthew R Weir, Willa A Hsueh, Shawna D Nesbitt, Thomas J Littlejohn, Alan Graff, Ali Shojaee

J Clin Hypertens (Greenwich)· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of amlodipine and olmesartan medoxomil in hypertensive patients with diabetes and obesity.
Henry Punzi, Ali Shojaee, William F Waverczak, Jen-Fue Maa

J Clin Hypertens (Greenwich)· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of hypertension in patients with diabetes using an amlodipine-, olmesartan medoxomil-, and hydrochlorothiazide-based titration regimen.
C Venkata Ram, Richard Sachson, Thomas Littlejohn, Chunlin Qian, Ali Shojaee

Am J Cardiol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
Dean J Kereiakes, Jen-Fue Maa, Ali Shojaee, Robert Dubiel

Am J Cardiovasc Drugs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Henry Punzi, Joel M Neutel, Dean J Kereiakes, Ali Shojaee, William F Waverczak

Ther Adv Cardiovasc Dis· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.
Seyed Mohammad Tavangar, Ali Shojaee, Hedieh Moradi Tabriz, Vahid Haghpanah, Bagher Larijani

Pathol Res Pract· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of an olmesartan medoxomil based treatment algorithm on 24-hour blood pressure control in patients with hypertension and type 2 diabetes.
Joel M Neutel, Dean J Kereiakes, William F Waverczak, Kathy A Stoakes, Jianbo Xu, Ali Shojaee

Curr Med Res Opin· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of an olmesartan medoxomil-based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and older.
Dean J Kereiakes, Joel Neutel, Kathy A Stoakes, William F Waverczak, Jianbo Xu, Ali Shojaee

J Clin Hypertens (Greenwich)· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis